Results 181 to 190 of about 2,290,618 (347)

Benzodiazepine and Opioid Withdrawal Induced Neuroleptic Malignant Like Syndrome: A Clinical Case Report With Management Complexities

open access: yesNeuropsychopharmacology Reports, Volume 45, Issue 2, June 2025.
This case report describes a 54‐year‐old man who developed Neuroleptic Malignant‐like Syndrome (NMLS) following the abrupt withdrawal of high‐dose benzodiazepines and opioids. The report highlights the diagnostic challenges in differentiating NMLS from Neuroleptic Malignant Syndrome and emphasizes the critical role of GABAergic dysregulation in its ...
Behnam Abbasi   +3 more
wiley   +1 more source

Sodium Oxybate‐Treated Familial Myoclonus‐Dystonia Syndrome Due to Novel SGCE Variant

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 5, May 2025.
ABSTRACT Myoclonus‐dystonia syndrome (MDS, OMIM #159900) is an autosomal‐dominant movement disorder caused by heterozygous variants in the epsilon sarcoglycan gene (SGCE) and characterized by a combination of myoclonic jerks, dystonia, and psychiatric comorbidities.
Malak Ali Alghamdi   +10 more
wiley   +1 more source

Altered stressor-induced changes in GABAA receptor function in the cerebral cortex of adult rats exposed in utero to diazepam

open access: hybrid, 1993
Carol K. Kellogg   +3 more
openalex   +1 more source

Multimodal spatial gradients to explain regional susceptibility to fibrillar tau in Alzheimer's disease

open access: yesAlzheimer's &Dementia, Volume 21, Issue 5, May 2025.
Abstract INTRODUCTION In Alzheimer's disease (AD), fibrillar tau gradually progresses from initial seed to larger brain area. However, those brain properties underlying the region‐dependent susceptibility to tau accumulation remain unclear. METHODS We constructed multimodal spatial gradients to characterize molecular properties and connectomic ...
Ying Luan   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy